OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity
Nicola Tumino, Francesca Besi, Stefania Martini, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 36
Nicola Tumino, Francesca Besi, Stefania Martini, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 36
Showing 26-50 of 36 citing articles:
The Perfect Combination of the Most Powerful Cancer Immunotherapy with the Best Targeted Chemotherapy
Vladimir N Pak
Cancer therapy & Oncology International Journal (2022) Vol. 20, Iss. 5
Open Access | Times Cited: 3
Vladimir N Pak
Cancer therapy & Oncology International Journal (2022) Vol. 20, Iss. 5
Open Access | Times Cited: 3
[Research Progress of Granulocytic Myeloid-derived Suppressor Cells
in Non-small Cell Lung Cancer].
Chaodan Yang, Rui Zhu, Yuting Zhang, et al.
PubMed (2024) Vol. 27, Iss. 1, pp. 65-72
Closed Access
Chaodan Yang, Rui Zhu, Yuting Zhang, et al.
PubMed (2024) Vol. 27, Iss. 1, pp. 65-72
Closed Access
Neuroblastoma Tumor Microenvironment: Innate and Adaptive Immunity
Michael J. Zobel, Shahab Asgharzadeh
Pediatric oncology (2024), pp. 123-141
Closed Access
Michael J. Zobel, Shahab Asgharzadeh
Pediatric oncology (2024), pp. 123-141
Closed Access
Comprehensive approach to cancer immunotherapy – Simultaneous targeting of myeloid-derived suppressor cells and cancer cells with AFP conjugates
Vladimir N Pak, Igor A. Sherman
Critical Reviews in Oncology/Hematology (2024) Vol. 200, pp. 104407-104407
Closed Access
Vladimir N Pak, Igor A. Sherman
Critical Reviews in Oncology/Hematology (2024) Vol. 200, pp. 104407-104407
Closed Access
Myeloid-derived suppressor cells: Identification and function
Paola Vacca, Maria Teresa Bilotta, Lorenzo Moretta, et al.
Methods in cell biology (2024), pp. 151-169
Closed Access
Paola Vacca, Maria Teresa Bilotta, Lorenzo Moretta, et al.
Methods in cell biology (2024), pp. 151-169
Closed Access
The Role of MDSCs in Digestive System Tumors and Research Progress in Targeted Therapy
丽葶 黄
Advances in Clinical Medicine (2024) Vol. 14, Iss. 09, pp. 925-933
Closed Access
丽葶 黄
Advances in Clinical Medicine (2024) Vol. 14, Iss. 09, pp. 925-933
Closed Access
A Cancer Prevention and Treatment Opportunity
Vladimir N Pak
Global Journal of Medical Research (2023), pp. 7-15
Open Access | Times Cited: 1
Vladimir N Pak
Global Journal of Medical Research (2023), pp. 7-15
Open Access | Times Cited: 1
In vitro preliminary study on different anti-PD-1 antibody concentrations on T cells activation
Irena Wieleba, Kamila Wojas‐Krawczyk, Izabela Chmielewska, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Irena Wieleba, Kamila Wojas‐Krawczyk, Izabela Chmielewska, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Alpha-Fetoprotein Binds Toxins and Can Be Used to Treat Cancer
Vladimir N Pak
Medical Research Archives (2022) Vol. 10, Iss. 10
Open Access | Times Cited: 2
Vladimir N Pak
Medical Research Archives (2022) Vol. 10, Iss. 10
Open Access | Times Cited: 2
Innate immune effectors in cancer
Lorenzo Moretta, Paola Vacca
Seminars in Immunology (2023) Vol. 67, pp. 101760-101760
Open Access
Lorenzo Moretta, Paola Vacca
Seminars in Immunology (2023) Vol. 67, pp. 101760-101760
Open Access
